Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04468321 · ClinicalTrials.gov registry record · NA
Heart Watch Study: a Pragmatic Randomized Controlled Trial
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
NCT04468321 is a NA study that has completed, run by Yale University. The registered enrollment target is 105 participants.
The verdict
NCT04468321, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
Study Summary
This will be a prospective multi-center, randomized, controlled trial of 150 patients conducted to assess the impact of individual use of the Apple Watch compared to the Withings Move on patient-reported and clinical outcomes at 6 months and up to 1 year.
Interventions
- DEVICE Apple Watch
- DEVICE Withings Move
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2021-08-18 |
| Est. Completion | 2024-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04468321
The ClinicalTrials.gov registry entry for NCT04468321 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Apple Watch is the first listed.
NCT04468321 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04468321 about?
NCT04468321 is a clinical study titled "Heart Watch Study: a Pragmatic Randomized Controlled Trial". This will be a prospective multi-center, randomized, controlled trial of 150 patients conducted to assess the impact of individual use of the Apple Watch compared to the Withings Move on patient-reported and clinical outcomes at 6 months and up to 1 year.
What is the current status of trial NCT04468321?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2021-08-18. Estimated completion is 2024-06-01.
What interventions are being tested in trial NCT04468321?
The interventions under investigation include: Apple Watch (DEVICE), Withings Move (DEVICE).
Who is sponsoring clinical trial NCT04468321?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.